NEHA PARMAR: Open Payments
NPI 1770238529 · SOMERVILLE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 7 payments from 4 companies in 2025. Trend: 2023 $747 · 2024 $311 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $158 |
| Amgen Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $30 |
| Galderma Laboratories, L.P. | 1 | $22 |
Products named: Bimzelx, OTEZLA, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
